Skip to main content
Strept pneumoniae vaccinations are underutilized. A Univ of Pittsburgh project utilized EMR reminders to prompt vax w/ P

Dr. John Cush RheumNow

5 years ago
Strept pneumoniae vaccinations are underutilized. A Univ of Pittsburgh project utilized EMR reminders to prompt vax w/ Prevnar/PCV13 & Pneumovax/PPSV23. PPSV23 vax increased 28% to 62% and either PPSV23, PCV13 incr 50% to 77% using EMR https://t.co/DO9WnyBHI1
MMWR: COVID-19–hospitalization rates in kids & adolescents rose 5-fold late June–mid-Aug 2021 (w/ rise of Delta

Dr. John Cush RheumNow

5 years ago
MMWR: COVID-19–hospitalization rates in kids & adolescents rose 5-fold late June–mid-Aug 2021 (w/ rise of Delta variant). Hospitalization rates were 10 times higher among unvaccinated than fully vaccinated adolescents. https://t.co/Qt5lj3Ycxb
 A Mayo Clinic/ Olmsted County study of psoriatic arthritis (PsA) patients has shown that more than half (55%) of PsA patients had a diagnostic delay of > 2 years, and that this delay has not improved over time.
https://t.co/wM1iRxtHvk

The interleukin-6 inhibitor, tocilizumab (TCZ), was studied in a cohort of difficult systemic s

Dr. John Cush RheumNow

5 years ago
https://t.co/wM1iRxtHvk The interleukin-6 inhibitor, tocilizumab (TCZ), was studied in a cohort of difficult systemic sclerosis (SSc) and was shown to be effective in refractory joint and skin disease with good long-term retention rates and disease stabilization. https://t.co/UBjpHUlb1l
Musculoskeletal sequelae/complications in adults following ICU admission studied by metanalysis of 32 studies. Muscle pr

Dr. John Cush RheumNow

5 years ago
Musculoskeletal sequelae/complications in adults following ICU admission studied by metanalysis of 32 studies. Muscle problems, pain (shoulder pain) predominated. Weakness in 29%, Chronic pain 34%, neuromuscular impairment 51%. https://t.co/FpqDvRDtVq
Wow! I hope you read part I of yesterday's “Greatest Rheumatologist” article.  So many big names and yet, other names and stories that were equally inspirational. If you read the comments of the part I article you can clearly see several themes emerge.
RT @jeffsparks: Our latest @MassGenBrigham rheumatology COVID collaboration with @zach_wallace_md #preprint to share qui

Jeffrey Sparks MD MMSc jeffsparks

5 years ago
Our latest @MassGenBrigham rheumatology COVID collaboration with @zach_wallace_md #preprint to share quickly. 16 confirmed breakthrough infections in rheumatic patients since vaccine EUAs in US. 15 symptomatic, 6 hospitalized, 2 deaths https://t.co/atixfBcEbn
RT @jeffsparks: Pleased to share our study in A&R investigating rheum evaluation, immunomodulator use, and predictor

Jeffrey Sparks MD MMSc jeffsparks

5 years ago
Pleased to share our study in A&R investigating rheum evaluation, immunomodulator use, and predictors of rheumatic immune-related adverse events (irAEs) after immune #checkpoint inhibitor use for cancer, led by @BusselKiki @BrighamResearch @DanaFarber https://t.co/6rnSfd08FB
Who is the greatest rheumatologist? What makes for a great rheum? Is it clinical acumen, scientific achievement, educational prowess or years of unrivaled service or mentoring? Rheumatologists are quite opinionated on this subject and very nostalgic about their mentors and leaders. When I’ve posed this question in small groups, it’s plain to see how moved they become when discussing mentors or peers who influenced them. Thus, I posed this
MMWR: COVID-19–hospitalization rates in kids & adolescents rose 5-fold late June–mid-Aug 2021 (w/ rise of Delta

Dr. John Cush RheumNow

5 years ago
MMWR: COVID-19–hospitalization rates in kids & adolescents rose 5-fold late June–mid-Aug 2021 (w/ rise of Delta variant). Hospitalization rates were 10 times higher among unvaccinated than fully vaccinated adolescents. https://t.co/Qt5lj3Ycxb https://t.co/p2e0KoiAXr
#Fatigue in the ARCTIC study studied using a 0-100 VAS over 24 mos. Baseline median fatigue 37mm & DAS=3.4. Fatigue

Dr. John Cush RheumNow

5 years ago
#Fatigue in the ARCTIC study studied using a 0-100 VAS over 24 mos. Baseline median fatigue 37mm & DAS=3.4. Fatigue declined 69% to 38% @24 mos. Predictors: low dz activity & high pt global. No remission at 6 mos assoc w/ fatigue at 24 mos https://t.co/NDk8fvr7Mq
ICYMI:

Belimumab in Pregnancy? a study of 13 pregnancies in 13 pts, mean age 38 yrs.. There were 11 live births, 1 case

Dr. John Cush RheumNow

5 years ago
ICYMI: Belimumab in Pregnancy? a study of 13 pregnancies in 13 pts, mean age 38 yrs.. There were 11 live births, 1 case omphalitis (recovered w Abx) . No fetal anomalies found. 6 pts (46%) w/ Hx of recurrent pregnancy loss, four had live births on BEL https://t.co/FJJhepa25M
×